Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts

被引：0
|
作者：
Bernd Lenz
Eva Schöpp
Christian P. Müller
Stefan Bleich
Thomas Hillemacher
Johannes Kornhuber
机构：
[1] Friedrich-Alexander-University of Erlangen-Nuremberg,Department of Psychiatry and Psychotherapy
[2] Hannover Medical School,Center for Addiction Research (CARe), Department of Psychiatry, Social Psychiatry and Psychotherapy
来源：
Psychopharmacology | 2012年 / 224卷
关键词：
Alcohol dependence; Craving; SRD5A2; Testosterone; Leptin; V89L;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：421 / 429
页数：8
相关论文
共 47 条
  • [21] A comprehensive systematic review of studies on the potential of A49T and V89L polymorphism in SRD5AR2 as high susceptibility gene association with benign prostate hyperplasia and prostate cancer
    Maharani, Revina
    Lestari, Hotma
    Dewa, Putra Mahakarya
    Yudisthira, Dewangga
    Amar, Nasim
    Daryanto, Besut
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2025, 96 (01)
  • [22] V89L(rs523349) and A49T(rs9282858) variations on SRD5A2 gene on dutasteride efficacy and safety in bladder cancer patients: A pilot study
    Incir, C.
    Gumustekin, M.
    Korhan, P.
    Ozer, M.
    Sarikaya, A.
    Bozkurt, O.
    Atabey, N.
    Esen, A.
    Tuncok, Y.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S99 - S100
  • [23] Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk:: An explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors
    Cussenot, Oliuier
    Azzouzi, Abdel-Rahmene
    Nicolaiew, Nathalie
    Mangin, Philippe
    Cormier, Luc
    Fournier, Georges
    Valeri, Antoine
    Cancel-Tassin, Geraldine
    EUROPEAN UROLOGY, 2007, 52 (04) : 1082 - 1089
  • [24] A polymorphism in 5-alpha-reductase (SRD5A2) gene shows novel association with prostate cancer
    Minarik, M.
    Benesova, L.
    Fantova, L.
    Heracek, J.
    Urban, M.
    Loukola, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 49 - 49
  • [25] SRDSA2 V89L Polymorphism and Prostate Cancer Risk: A Meta-Analysis
    Wang, Chunyang
    Tao, Weiyang
    Chen, Qiyin
    Hu, Hailong
    Wen, Xiao-Yan
    Han, Ruifa
    PROSTATE, 2010, 70 (02): : 170 - 178
  • [26] The valine allele of the V89L polymorphism in the 5-α-reductase gene confers a reduced risk for hypospadias
    Thai, HTT
    Kalbasi, M
    Lagerstedt, K
    Frisén, L
    Kockum, I
    Nordenskjöld, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12): : 6695 - 6698
  • [27] Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men
    Allen, NE
    Reichardt, JKV
    Nguyen, H
    Key, TJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (06) : 578 - 581
  • [28] V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression
    Nam, RK
    Toi, A
    Vesprini, D
    Ho, M
    Chu, W
    Harvie, S
    Sweet, J
    Trachtenberg, J
    Jewett, MAS
    Narod, SA
    UROLOGY, 2001, 57 (01) : 199 - 204
  • [29] The association between polymorphisms in the CYP17 and 5α-reductase (SRD5A2) genes and serum androgen concentrations in men
    Allen, NE
    Forrest, MS
    Key, TJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (03) : 185 - 189
  • [30] The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism
    Shiota, M.
    Fujimoto, N.
    Yokomizo, A.
    Takeuchi, A.
    Kashiwagi, E.
    Dejima, T.
    Kiyoshima, K.
    Inokuchi, J.
    Tatsugami, K.
    Eto, M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (02) : 191 - 196
12345